CytomX Therapeutics Inc (CTMX)
1.675
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 13:30
CytomX Therapeutics Profit Margin (Quarterly): 3.15% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.15% |
| September 30, 2023 | 11.34% |
| June 30, 2023 | -4.40% |
| March 31, 2023 | -14.09% |
| December 31, 2022 | -43.61% |
| September 30, 2022 | -260.7% |
| June 30, 2022 | -229.5% |
| March 31, 2022 | -353.8% |
| December 31, 2021 | |
| September 30, 2021 | -128.4% |
| June 30, 2021 | -118.1% |
| March 31, 2021 | -97.39% |
| December 31, 2020 | |
| September 30, 2020 | -82.70% |
| June 30, 2020 | -94.41% |
| March 31, 2020 | 24.61% |
| December 31, 2019 | |
| September 30, 2019 | -221.2% |
| June 30, 2019 | -321.3% |
| Date | Value |
|---|---|
| March 31, 2019 | -47.90% |
| December 31, 2018 | -281.0% |
| September 30, 2018 | -187.3% |
| June 30, 2018 | -63.02% |
| March 31, 2018 | -109.2% |
| December 31, 2017 | 2.29% |
| September 30, 2017 | -42.44% |
| June 30, 2017 | -288.1% |
| March 31, 2017 | -70.86% |
| December 31, 2016 | -223.7% |
| September 30, 2016 | -424.5% |
| June 30, 2016 | -458.2% |
| March 31, 2016 | -721.1% |
| December 31, 2015 | -577.8% |
| September 30, 2015 | -612.2% |
| June 30, 2015 | -284.2% |
| March 31, 2015 | -356.5% |
| December 31, 2014 | -257.2% |
| September 30, 2014 | -187.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-353.8%
Minimum
Mar 2022
24.61%
Maximum
Mar 2020
-120.7%
Average
-95.90%
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 33.77% |
| Sarepta Therapeutics Inc | 11.51% |
| Puma Biotechnology Inc | 17.00% |
| Ocular Therapeutix Inc | -197.4% |
| Bristol-Myers Squibb Co | 15.35% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -0.25% |
| Operating Margin (Quarterly) | -2.28% |
| Return on Net Operating Assets | -1.94% |